Functional Significance of Vitamin D Receptor FokI Polymorphism in Human Breast Cancer Cells
2011

Vitamin D Receptor Polymorphism and Breast Cancer

publication 10 minutes Evidence: moderate

Author Information

Author(s): Alimirah Fatouma, Peng Xinjian, Murillo Genoveva, Mehta Rajendra G.

Primary Institution: Illinois Institute of Technology

Hypothesis

The FokI vitamin D receptor polymorphism affects breast cancer cell response to vitamin D treatment.

Conclusion

The VDRff genotype may contribute to more aggressive breast cancer, while VDRFF cells respond better to vitamin D treatment.

Supporting Evidence

  • VDRFF cells showed 60% growth inhibition in response to vitamin D compared to 28% in VDRff cells.
  • CYP24A1 mRNA was 1.8 times higher in VDRFF cells than in VDRff cells after vitamin D treatment.
  • Estrogen receptor-α expression was downregulated by 62% in VDRFF cells compared to 25% in VDRff cells.

Takeaway

Some versions of a vitamin D receptor can make breast cancer cells grow faster, while others help the cells respond better to vitamin D treatment.

Methodology

MCF-7 breast cancer cell lines were established and treated with vitamin D to assess growth inhibition and gene expression.

Potential Biases

Potential selection bias in cell line characteristics and responses.

Limitations

The study may not account for all genetic and environmental factors influencing breast cancer risk.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016024

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication